Daawo cusub oo lagu daweeyo kansarka beerka

La qaybso Post this

Koox cilmi baaris ah oo ka tirsan Machadka Cilmi-baarista Kansarka (CSI) ee Jaamacadda Qaranka ee Singapore waxay soo saareen dawada peptide-ga cusub ee loo yaqaan FFW taasoo ka hortagi karta horumarinta kansarka hepatocellular (HCC) ama aasaasiga ah. kansarka beerka . Daahfurkan taariikhiga ah wuxuu albaabka u furayaa daawaynta waxtarka leh ee kansarka beerka iyo hoos u dhaca waxyeelada.

SALL4 is a protein associated with tumor growth and has been used as a prognostic marker and drug target for HCC, lung cancer and leukemia. It is usually present in a growing fetus, but is inactive in adult tissues. In some cancers, such as HCC, SALL4 is reactivated, leading to buro koritaanka.

Molekuyuleyaasha daroogada ee ku shaqeeya borotiinka, sida SALL4-NuRD, waxay badanaa u baahan yihiin borotiinka la bartilmaameedsanayo inuu haysto “jeeb” yar oo qaab-dhismeedka 3-D ah, halkaasoo molikuyuullada daroogadu ka jiri karto oo shaqeyn karto. Baadhitaankii hore, waxaa lagu ogaaday in borotiinka SALL4 uu la falgalo protein kale NuRD, sameynta iskaashi muhiim u ah horumarinta kansarka sida HCC. SALL4 oo ay soo diyaariyeen kooxdan cilmi baaristu ma aysan eegin 'jeebado', laakiin waxay qaabeeyeen biomolecules xannibaysa isdhexgalka SALL4 iyo NuRD. Daraasado ayaa lagu ogaaday in ka hortagga isdhexgalkaan ay sababi karto dhimashada unugyada burooyinka isla markaana yareyso dhaqdhaqaaqa unugyada burooyinka.

FFW can effectively block protein-protein interactions, and does not require “pockets” to take effect. The research team also found that when combined with sorafenib, FFW can reduce the growth of sorafenib-resistant HCC. Although most Daaweynta la beegsaday are small-molecule drugs, well-designed peptide drugs (such as FFW) tend to have higher selectivity than large-molecule surfaces and are less toxic than small molecules.

Baaraha reer Singapore Dr. Liu Bee Hui wuxuu yiri: Iyadoo lagu saleynayo macluumaadka aan ka helnay qaab dhismeedka iyo muujinta hiddo-wadaha caalamiga ah, waxaan sii wadeynaa inaan daraasad ku sameyno peptide-kaan iyo peptides-ka kale ee leh qaababka la midka ah si aan ugu dambeyntii uga dhigno iyaga daawooyinka heerka bukaan socodka oo aan ukeenno bukaanada waxtarka.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS
Kansarka

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS

Lutetium Lu 177 dotatate, oo ah daawayn hor leh, ayaa dhawaan ogolaansho ka heshay Maamulka Cunnada iyo Dawooyinka ee Maraykanka (FDA) ee bukaanada carruurta, taas oo calaamad u ah guul muhiim ah oo ku saabsan kansarka carruurta. Oggolaanshahani waxa uu u taagan yahay iftiin rajo u ah carruurta la dagaallamaysa burooyinka neuroendocrine (NETs), oo ah nooc naadir ah laakiin adag oo kansar ah kaas oo inta badan caddeeya u adkaysiga daaweynta caadiga ah.

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG
Kansarka kaadiheysta

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG

"Nogapendekin Alfa Inbakicept-PMLN, immunotherapy novel, waxay muujinaysaa ballanqaad daawaynta kansarka kaadiheysta marka lagu daro daawaynta BCG. Habkan cusubi waxa uu bartilmaameedsanayaa calaamado gaar ah oo kansar ah iyada oo la xoojinayo jawaabta habka difaaca jidhka, iyada oo kor u qaadeysa waxtarka daaweynta dhaqameed sida BCG. Tijaabooyin caafimaad ayaa muujinaya natiijooyin dhiirigelin leh, oo muujinaya natiijooyinka bukaan-socodka oo soo hagaagay iyo horumarka suurtagalka ah ee maareynta kansarka kaadiheysta. Is-waafajinta ka dhexeeya Nogapendekin Alfa Inbakicept-PMLN iyo BCG waxay ku bishaaraynaysaa waa cusub oo daawaynta kansarka kaadiheysta."

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton